The Cochrane Cystic Fibrosis and Genetic Disorders group is an international network of healthcare professionals, researchers and consumers preparing, maintaining, and disseminating systematic reviews of randomised control trials for treating cystic fibrosis and other genetic disorders (haemoglobinopathies. coagulopathies and inborn errors of metabolism).
The Cochrane Fertility Regulation group addresses the process by which people regulate their fertility, family size and spacing of births.
The Cochrane Gynaecology and Fertility group is concerned with the systematic evaluation of the management and treatment of menstrual disorders and subfertility
The Cochrane Incontinence group prepares, maintains, and disseminates systematic reviews of the effectiveness of interventions for incontinence, including prevention, treatment and rehabilitation, concentrating on randomised controlled trials.
The Cochrane Neonatal group prepare and disseminate evidence-based, regularly updated reviews of the effects of therapies in neonatal-perinatal medicine (interventions involving the baby during the first month after birth).
The Cochrane Pregnancy and Childbirth group focus on interventions involving the mother or baby during and after pregnancy and childbirth (including lactation).
Cochrane Sexually Transmitted Infections focus on the prevention, diagnosis, and treatment of sexually transmitted infections and genital tract infections.